On Thursday, January 11, researchers, donors and staff gathered to celebrate the official opening of the RI-MUHC Centre for Outcomes Research and Evaluation (CORE) in its new home on 5252 boulevard de Maisonneuve. Created in 2013, CORE comprises more than 90 experts in epidemiology, biostatistics, clinical trials and health services research who work to improve the health and health care of Canadians. Previously scattered in various locations, these researchers as well as over 350 trainees and professional staff are now finally united under one roof. Funding for the new infrastructure, which is located a few steps away from the Glen site, was supported in large part by the MUHC Foundation via the Best Care for Life Campaign and by the federal-provincial Strategic Investment Fund.
“CORE’s 90+ researchers strive to prevent illness, develop and test new diagnostic tools and treatments, and improve health care across the lifecourse. The road between discovery and translation of results from CORE research is often quite short. With nearly $100M in research funding received over the last 4 years, CORE researchers have made outstanding contributions to developing clinical programs and strategies to improve maternal and child health, cardiovascular disease, cancer, depression, diabetes, and other chronic diseases.” – Micheal Kramer, Director, CORE.
One example of the innovative work being done at CORE is the research into type 2 diabetes being done by Dr. Kaberi Dasgupta, Co-Director of CORE. Type 2 diabetes is a serious illness that can lead to heart attacks, strokes, and blindness if left unmanaged, but Dr. Dasgupta is working to change this outcome one step at a time. Research has shown that regular walking can lead to a 40 percent reduction in the mortality rate over the next decade for adults with type 2 diabetes. With people walking under 5,000 steps at a high risk of developing type 2 diabetes, Dr. Dasgupta’s recent research demonstrated that that physician-delivered step count prescriptions, combined with the use of a pedometer, led to a 20 per cent increase in daily steps, as well as measurable health benefits, such as lower blood sugar and lower insulin resistance.